4 completed. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
Follow Abyss Ingredients: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms Placebo, ACT01, ACT02 - Atopic Dermatitis, Eczema | Not applicable | Completed | Abyss Ingredients | 92 | 2024-01-09 | 2024-08-21 |
| Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging Blue fish hydrolysate, Placebo - Memory Impairment, Age-related Cognitive Decline | Not applicable | Completed | Abyss Ingredients | 53 | 2021-09-14 | 2024-01-09 |
| Efficacy of the Marine Based Nutritional Supplement Peptidyss® on Sleep and Anxiety Fish Hydrolysate, Placebo - Sleep Disorder | Not applicable | Completed | Abyss Ingredients | 45 | 2021-07-19 | 2022-08-17 |
| Hydrolyzed Fish Cartilage Effect on Knee Joint Functionality and Discomfort in Adult Population Cartidyss - Knee Discomfort | Not applicable | Completed | Abyss Ingredients | 32 | 2020-06-11 | 2021-01-06 |
Anxiety Disorders (1) · Cognitive Dysfunction (1) · Dermatitis, Atopic (1) · Eczema (1) · Memory Disorders (1) · Sleep Wake Disorders (1)
Belgium (1) · France (1) · Germany (1) · Spain (1)
Charles Chapelle, MD (1) · Juliane Hellhammer, PhD (1)